Cargando…
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
BACKGROUND: Inability to tolerate statins because of muscle symptoms contributes to uncontrolled cholesterol levels and insufficient cardiovascular risk reduction. Bempedoic acid, a prodrug that is activated by a hepatic enzyme not present in skeletal muscle, inhibits ATP‐citrate lyase, an enzyme up...
Autores principales: | Laufs, Ulrich, Banach, Maciej, Mancini, G. B. John, Gaudet, Daniel, Bloedon, LeAnne T., Sterling, Lulu Ren, Kelly, Stephanie, Stroes, Erik S. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509724/ https://www.ncbi.nlm.nih.gov/pubmed/30922146 http://dx.doi.org/10.1161/JAHA.118.011662 |
Ejemplares similares
-
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019) -
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
por: Banach, Maciej, et al.
Publicado: (2020) -
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
por: Cicero, Arrigo F. G., et al.
Publicado: (2020) -
Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022) -
Bempedoic acid: A nonstatin drug for the management of hypercholesterolemia
por: Govindaraju, Asvitha, et al.
Publicado: (2021)